From Preclinical to Commercial,
We Scale with You

LOTTE Biologics delivers flexible, scalable manufacturing solutions across the full product lifecycle, supporting programs from early development through commercial supply. Our capabilities span mammalian-cell-based drug substance production, high-titer and large-scale bioreactor operations, and fully integrated Bioconjugation manufacturing at our Syracuse campus. With a unified Dual Hub model, advanced technologies, and consistent global quality standards, we provide reliable, phase-appropriate execution to meet the diverse needs of our partners' therapeutic pipelines.